Andrzej K Bednarek Selected Research

Radical Mastectomy

2/2009	Prognostic relevance of cyclin E expression in operable breast cancer.
12/2006	A comparative assessment of HER2 status in operable breast cancer by real-time RT-PCR and by immunohistochemistry.
3/2006	Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining.
1/2006	Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej K Bednarek Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 06/2004
12	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2005
6	Carcinogenesis 05/2022 - 02/2008
2	Hypoxia (Hypoxemia) 03/2022 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 03/2021
2	Carcinoma (Carcinomatosis) 02/2021 - 02/2008
2	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 02/2013
1	Hyperglycemia 03/2022
1	Glioblastoma (Glioblastoma Multiforme) 06/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021
1	Lung Neoplasms (Lung Cancer) 12/2020
1	Adenocarcinoma of Lung 09/2020
1	Drug Resistant Epilepsy 01/2020
1	Triple Negative Breast Neoplasms 01/2017
1	Adenocarcinoma 01/2015
1	Asthma (Bronchial Asthma) 12/2009
1	Rhabdomyosarcoma 01/2007
1	Leukemia 11/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2021 - 06/2004
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
5	Biological ProductsIBA 12/2020 - 06/2004
4	Estrogens (Estrogen)FDA Link 05/2022 - 08/2009
4	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2019
4	Cyclin EIBA 02/2009 - 01/2005
3	SteroidsIBA 05/2022 - 01/2015
3	Estrogen ReceptorsIBA 05/2022 - 03/2010
3	WW Domain-Containing OxidoreductaseIBA 03/2021 - 01/2020
2	Hormones (Hormone)IBA 05/2022 - 01/2017
2	Small Interfering RNA (siRNA)IBA 05/2022 - 02/2008
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2021
2	Progesterone FDA LinkGeneric 08/2019 - 08/2009
2	Steroid Receptors (Steroid Receptor)IBA 02/2009 - 01/2007
1	Oxidoreductases (Dehydrogenase)IBA 05/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2022
1	Matrix Metalloproteinases (MMPs)IBA 06/2021
1	MicroRNAs (MicroRNA)IBA 02/2021
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	CarcinogensIBA 09/2020
1	SmokeIBA 09/2020
1	Nonsense Codon (Nonsense Mutation)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 08/2019
1	SuspensionsIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Complementary DNA (cDNA)IBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2013
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	Phosphotransferases (Kinase)IBA 02/2013
1	CyclinsIBA 10/2012
1	chlorambucil-arachidonic acid conjugateIBA 12/2009
1	LeukotrienesIBA 12/2009
1	VimentinIBA 08/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2009
1	Pharmaceutical PreparationsIBA 02/2008
1	Glycoproteins (Glycoprotein)IBA 02/2008
1	beta CateninIBA 02/2008
1	DesminIBA 01/2007
1	Cadherins (E-Cadherin)IBA 01/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2006
1	AnthracyclinesIBA 11/2005
1	Keratins (Keratin)IBA 01/2005

Therapy/Procedure

4	Radical Mastectomy 02/2009 - 01/2006
2	Therapeutics 01/2022 - 11/2005
1	Radiotherapy 12/2020
1	Adjuvant Chemotherapy 02/2009